European Archives - Page 1102 of 1163 - European Medical Journal

EMJ

Biosense Webster Launches CARTO® 3 System CONFIDENSE™ Module for Optimized High-Density Mapping During Catheter Ablation Procedures

Diamond Bar, Calif., June 18, 2015 – Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced today…

EMJ

Interview: Abolfazl Hosseni

An Interview with Dr. Abolfazl Hosseni at the 11th National Endourology Congress, Discussing the Developing Treatment in Bladder Cancer

EMJ

Interview: Abhay Rane

An Interview with Dr. Abhay Rane at the 11th National Endourology Congress, Discussing the Key Points of the Upcoming World Congess of Endourology

EMJ

Interview: John W. Davis

An Interview with Dr. John W. Davis at the 11th National Endourology Congress, Discussing the Key Points from the Congress

EMJ

Interview: Kevin C. Zorn

An Interview with Dr. Kevin C. Zorn at the 11th National Endourology Congress, Discussing Developments within the Field

EMJ Urology 3.3 2015

Hello and a very warm welcome to another fascinating edition of European Medical Journal Urology – your trusted source for all of the latest innovations…

EMJ

First ESC Recommendations for Arrhythmias and Chronic Kidney Disease Published

Milan, Italy – 24 June 2015: The first ESC recommendations for patients with cardiac arrhythmias and chronic kidney disease (CKD) are presented today…

EMJ

Uninterrupted NOAC Therapy during AF Ablation Is Safe

Milan, Italy – 24 June 2015: Uninterrupted treatment with novel oral anticoagulants (NOACs) during catheter ablation of atrial fibrillation (AF) is safe…

EMJ

ESC Recommends Uninterrupted Vitamin K Antagonists during Ablation and Device Implantation

Milan, Italy – 23 June 2015: The European Society of Cardiology (ESC) has recommended uninterrupted anticoagulation with vitamin K antagonists…

EMJ

New Biomarkers Could Shine Beacon for Personalised Hepatitis C Therapy

BLOOD tests can be used to predict which chronic hepatitis C patients will respond to interferon-based therapy. “While highly effective direct-acting…